See more : Chinney Alliance Group Limited (0385.HK) Income Statement Analysis – Financial Results
Complete financial analysis of North Springs Resources Corp (NSRS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of North Springs Resources Corp, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Tele Columbus AG (TC1.DE) Income Statement Analysis – Financial Results
- bioMérieux S.A. (BMXMF) Income Statement Analysis – Financial Results
- Grange Resources Ltd (GRR.AX) Income Statement Analysis – Financial Results
- Allison Transmission Holdings, Inc. (ALSN) Income Statement Analysis – Financial Results
- Grounded Lithium Corp. (GRD.V) Income Statement Analysis – Financial Results
North Springs Resources Corp (NSRS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
About North Springs Resources Corp
North Springs Resources Corp. focuses on the evaluation, acquisition, exploration, and development of mineral resource properties. It also focuses on the acquisition and development of various products and services in the pharmaceutical and medical technology industries. The company was formerly known as Aurum Resources Corp. and changed its name to North Springs Resources Corp. in June 2011. North Springs Resources Corp. was founded in 2009 and is based in Riverview, Florida.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2010 |
|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 987.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | -987.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 7.80K | 10.00K | 40.60K | 37.07K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 7.62 | 0.00 | 0.00 |
| SG&A | 0.00 | 0.00 | 7.80K | 17.62K | 40.60K | 37.07K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 0.00 | 0.00 | 7.80K | 17.62K | 40.60K | 37.07K |
| Cost & Expenses | 0.00 | 0.00 | 7.80K | 18.61K | 40.60K | 37.07K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 6.00K | 0.00 |
| Depreciation & Amortization | 228.49K | 236.56K | 206.30K | 171.86K | 161.14K | 0.00 |
| EBITDA | 0.00 | 0.00 | -7.80K | 153.25K | -40.60K | -47.07K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | 0.00 | 0.00 | -7.80K | -18.61K | -40.60K | -27.07K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 0.00 | 0.00 | 0.00 | 0.00 | -6.00K | -10.00K |
| Income Before Tax | 0.00 | 0.00 | -7.80K | -18.61K | -46.60K | -37.07K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 0.00 | -6.41K | 0.00 | 0.00 | 10.00K |
| Net Income | 0.00 | 0.00 | -7.80K | -18.61K | -46.60K | -47.07K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.65 |
| EPS Diluted | 0.00 | 0.00 | -0.05 | 0.00 | 0.00 | -0.65 |
| Weighted Avg Shares Out | 0.00 | 0.00 | 344.02M | 0.00 | 359.02M | 72.35K |
| Weighted Avg Shares Out (Dil) | 0.00 | 0.00 | 159.02K | 0.00 | 359.02M | 72.35K |
Source: https://incomestatements.info
Category: Stock Reports